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the verification of treatment delivery. Using the real-time 
cumulative χ we are able to demonstrate an improved ability 
to identify small but potentially significant positional errors 
when compared to using only the integrated image χ value.  
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Purpose/Objective: Proton computed tomography (CT) has 
been described as a solution to image the proton relative 
stopping power (RSP) of patient tissues and could therefore 
reduce the uncertainty and associated margins of the 
conversion of X-ray CT images to RSP maps. Several studies 
have already demonstrated the capability of proton imaging 
to reconstruct tissue RSP but the quantification of the 
improvement with respect to X-ray CT is still missing. This 
study aimed at quantifying the accuracy of RSP maps 
reconstructed from X-ray and proton CT and their impact on 
the prediction of proton ranges under idealized conditions, 
i.e., perfect detectors for the position and the energy of 
protons and realistic but perfectly known X-ray source and 
flat panel. 
Materials and Methods: We have developed a Monte Carlo 
framework to assess proton CT performances for the main 
steps of a proton therapy treatment planning, i.e., proton or 
X-ray CT acquisition and reconstruction, conversion to RSP 
maps based on the calibration of a tissue phantom, and 
proton dose simulations. The RSP maps obtained from X-ray 
CT images rely on the calibration curve that converts 
Hounsfield units into RSP. Two different approaches (linear 
interpolation and least-squares minimization) were tested to 
determine the impact of this calibration. In-silico pencil 
beams were simulated to a computational phantom on 
various anatomical sites and the proton range was assessed 
on the reference, the proton CT-based and the X-ray CT-
based material maps. 
Results: The imaging dose delivered by a proton CT scanner 
appeared impressively uniform and conformal to the imaging 
beam. Comparison of the RSP maps showed that proton CT 
enables a more precise RSP reconstruction of all anatomical 
sites (Figure 1). The spatial distribution of the RSP deviation 
also shows that the accuracy of proton CT reconstruction is 
more uniform. This weaker tissue dependence could help to 
produce a more robust estimate of the proton range between 
patients. As expected from the RSP reconstruction, proton CT 
gave a more precise estimate of the proton range with a 
mean range deviation of only 0.3%, which was at least 60% 
smaller than the X-ray CT predictions. 
 
Figure 1. Absolute deviation of the RSP for liver, head and 
lungs sites for proton CT (left) and for X-ray CT using a 
linearly interpolated calibration (middle) or a least-squares 
fit (right). 
Conclusions: A Monte Carlo framework has been developed 
to assess the performances of proton CT for the simulation of 
the patient dose in proton therapy. Considering ideal 
detectors performances, the reconstructed RSP maps with 
proton CT were more accurate than the RSP maps obtained 
from X-ray CT images. Proton range calculations based on 
proton CT are therefore both more precise and more uniform 
with a weaker dependence to the spatial distribution of 
tissues. Smaller treatment margins could therefore be used if 
proton CT was available to plan proton therapy. Proton CT 
also benefits from the uniformity of the imaging dose 
distribution and its high conformation to the primary beam 
region.  
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Purpose/Objective: Particle induced x-ray emission (PIXE), 
commonly based on detection of characteristic x-rays upon 
irradiation with a low-energy proton beam, is a useful tool 
for high-sensitivity material analysis of thin samples. We 
propose to investigate the feasibility of proton induced x-ray 
fluorescence (pXRF) for range verification in proton therapy. 
The goal of this work was to demonstrate the feasibility of 
proton-induced x-ray fluorescence CT (pXFCT) imaging of 
gold placed in a phantom by means of experiments and Monte 
Carlo (MC) simulations. 
Materials and Methods: First, proton induced gold x-ray 
fluorescence (pXRF) was measured as a function of gold 
concentration. Vials of 2.2 cm in diameter filled with 0-5% Au 
solutions were irradiated with a 3×1011 220 MeV protons of 7-
mm FWHM. X-ray fluorescence induced by the interaction of 
protons and Au was detected with a 3×3 mm2 CdTe detector 
placed at 90° with respect to the incident proton beam at a 
distance of 45 cm from the vials. Second, a 7-cm diameter 
water phantom containing three 2.2-diameter vials with 3%, 
4%, and 5% Au solutions was imaged with the 7-mm 220 MeV 
proton beam in a 1st generation CT scanning geometry 
(Figure 1a). 21 translational steps spaced by 3 mm at each of 
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36 projection angles spaced by 10° were acquired using an 
in-house built rotation/translation stage. During each 
projection data acquisition, approximately 1010 protons were 
delivered in 20 s while the stage moved over 3.5 mm. X-rays 
scattered perpendicular to the incident proton beam were 
acquired with the CdTe detector placed at 45 cm from the 
phantom. pXFCT images of the phantom were reconstructed 
with filtered back projection based on gold Kα1 (68.8 keV) 
and Kα2 (67.0 keV) x-ray fluorescence peaks extracted from 
the acquired x-ray spectra. A simplified geometry of the 
experimental data acquisition setup was modeled with the 
MC TOPAS code and simulation data were compared to the 
experimentally acquired data. 
Results: A linear relationship between gold pXRF and gold 
concentration was observed in both experimental and MC 
simulation data (R2>0.99). The experimental pXRF signal was 
approximately 1.7 times lower than the MC pXRF signal 
simulated with simplified geometry. All Au vials were clearly 
visible in the reconstructed experimental (Figure 1b) and 
simulated (Figure 1c) pXFCT images. Additionally, the 3% Au 
vial was detectable in both the experimental (CNR = 5.8) and 
simulated (CNR = 11.5) pXFCT images. Due to fluorescence x-
ray attenuation in the higher concentration vials, the 4% and 
5% Au contrast was underestimated by 10% and 15%, 
respectively, in both the experimental and simulated pXFCT 
images. 
 
 
Conclusions: Proton induced x-ray fluorescence CT imaging 
of gold in a 7-cm diameter phantom has been demonstrated 
for the first time by means of experiments and MC 
simulations. The study encourages us to investigate the use 
of proton induced x-ray fluorescence for gold marker tracking 
during proton radiotherapy. 
   
PD-0141   
An MRI based mid-ventilation approach for radiotherapy of 
liver cancer on an MR-linac 
T. Van de Lindt1, G. Schubert2, U. Van der Heide1, J.J. Sonke1 
1NKI, Radiation Oncology, Amsterdam, The Netherlands  
2Philips, Healthcare, Best, The Netherlands  
Purpose/Objective: With an integrated MRI and linear 
accelerator (MR-linac) under development, it will become 
possible to visualize even low contrast tumors at the time of 
irradiation and new MRI-based image guidance strategies for 
moving targets are required. In current practice, a 10 phase 
4DCT is acquired after which the phase closest to the time 
weighted average position of the tumor can be extracted. 
This is called the mid-ventilation (midV) anatomy and is the 
anatomy that minimizes systematic deviations for treatment 
planning and delivery of free-breathing patients. Therefore, 
an efficient strategy to acquire a high quality MRI image in 
midV was developed and evaluated, as a first step towards 
radiotherapy of moving tumors on an MR-linac. Additionally, 
respiratory induced motion was quantified and is to be 
included in the safety margins. 
Materials and Methods: In midV the velocity of the liver is 
high and images are thus sensitive to motion artifacts. 
Therefore, a fast, but low resolution (LR), image was 
acquired in midV (single-shot TSE, TE=100ms, TR=222ms, shot 
length=166ms), while interleaved, a high resolution (HR) 
image was acquired in the more stable exhale phase (multi-
shot TSE, TE=100ms, TR=2180ms, shot length=234ms, 
res=1x1x4mm, NSA=3). The HR image was deformably 
registered (DR), using B-splines with mutual information, to 
the midV anatomy. In this way a high quality image in midV 
was obtained. Additionally, the motion of a local structure of 
the liver was derived from cine MRI, i.e., acquisition of two 
orthogonal 2D slices at 2fps. All measurements were 
performed on a 1.5T whole body MR system (Philips 
Healthcare, Best). 
Results: After deformable registration of the HR exhale scan 
to the midV anatomy, a good quality image in midV (DR 
midV) was obtained. It shows minimal motion artifacts and 
vascular structures are clearly visible (fig1a). In a sagittal 
view it is visible that the DR midV fits the midV anatomy 
much better than the exhale scan (fig1b). Motion of a local 
structure in the liver could be quantified from cine MRI using 
rigid image registration (fig2). SI and AP motion had standard 
deviations of 6 and 2mm respectively. LR motion was 
negligible.  
 
Conclusions: By using two alternating trigger levels, a fast, 
but low resolution, T2-weighted image in midV and a high 
resolution image in the more stable exhale phase were 
acquired efficiently. By deformably registering the high 
resolution image to the midV anatomy, a high quality image 
in midV could be realized for treatment planning and 
guidance of liver cancer radiotherapy on an MR-linac. Motion 
in three directions could be quantified from cine MRI and is 
to be included in the safety margins. Before clinical 
implementation, the accuracy of deformable registration 
amplitude assessment needs to be validated in a cohort of 
patients.  
   
 
 
 
 
